The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses-Reference-Cited by-同舟云学术

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses

Published:2011-11 Issue:17 Volume:47 Page:2517-2530
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Campbell H.E.,Epstein D.,Bloomfield D.,Griffin S.,Manca A.,Yarnold J.,Bliss J.,Johnson L.,Earl H.,Poole C.,Hiller L.,Dunn J.,Hopwood P.,Barrett-Lee P.,Ellis P.,Cameron D.,Harris A.L.,Gray A.M.,Sculpher M.J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference57 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial;Roche;J Clin Oncol,2006

3. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial;Ellis;Lancet,2009

4. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer;Poole;N Engl J Med,2006

5. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial;J Nat Cancer Inst,2007

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT;Health Technology Assessment;2023-11

2. Cost-utility analysis of genomic profiling in early breast cancer in Colombia;Cost Effectiveness and Resource Allocation;2023-07-10

3. Geriatric assessment prior to cancer treatment: A health economic evaluation;Journal of Geriatric Oncology;2023-07

4. Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis;Frontiers in Oncology;2023-06-23

5. Adverse events connected to breast cancer treatment and their associated decrease in quality of life scores;2022-11-29